MarketPeel
Insider Trading Intelligence
Pricing
…
CC

Christopher Michael Camarra

HOTH
DIRECTOR · HOTH THERAPEUTICS, INC. · CIK 0002069121
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
May 2026
HOLDINGS NOW
75,000
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Christopher Michael Camarra. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,000——75,000May 26, 2026May 28, 2026 ↗View →
Other insiders · HOTH
Loading peer insiders…
About this filer
CIK 0002069121
ROLE
Director
PRIMARY
HOTH
COMPANIES
1
ACTIVE SINCE
May 2026
MARKETPEEL · /INSIDER/0002069121DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback